1. Home
  2. Stocks
  3. Biocon Share Price
  • Chart
  • F&O
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Biocon Share Price Biocon

    Large Cap
    ₹306.4
    +14.75 (5.06%)
    • Advice
    • Hold
    28 April, 2024 03:08 BSE: 532523 NSE: BIOCONISIN: INE376G01013

    Start SIP in Biocon

    Start SIP

    Biocon Performance

    Day Range

    • Low 292
    • High 313
    ₹ 306

    52 Week Range

    • Low 218
    • High 313
    ₹ 306
    • Open Price292
    • Previous Close292
    • Volume45364974

    Biocon Share Price

    • Over 1 Month +18.9%
    • Over 3 Month +18.44%
    • Over 6 Month +37.96%
    • Over 1 Year +32.76%

    Biocon Key Statistics

    P/E Ratio 30.7
    PEG Ratio 0.1
    Market Cap Cr 36,786
    Price to Book Ratio 1.6
    EPS -0.1
    Dividend 0.5
    Relative Strength Index 71.24
    Money Flow Index 84.32
    MACD Signal 2.48
    Average True Range 10.22

    Biocon F&O

    Biocon Futures Biocon Option Chain
    Biocon Financials
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 563519513507
    Operating Expenses Qtr Cr 492452441551
    Operating Profit Qtr Cr 716772-44
    Depreciation Qtr Cr 31313029
    Interest Qtr Cr 56554848
    Tax Qtr Cr 9113-15
    Net Profit Qtr Cr 2435471,811
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 2,264
    Operating Expenses Annual Cr 1,969
    Operating Profit Annual in Cr 24
    Depreciation Cr 117
    Interest Annual Cr 70
    Tax Annual Cr 123
    Net Profit Annual Cr 2,848
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 219
    Cash from Investing Activity Annual Cr -1,178
    Cash from Financing Annual Activity Cr 1,039
    Net Cash Flow Annual Cr 81
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 10,916
    Fixed Assets Annual Cr 1,305
    Total Non Current Assets Annual Cr 10,464
    Total Current Assets Annual Cr 2,566
    Total Assets Annual Cr 13,030
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 91
    ROE Annual % 26
    ROCE Annual % 1
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 15
    Sign Up to Know More
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 3,5493,4623,4233,774
    Operating Expenses Qtr Cr 3,0272,7212,7082,777
    Operating Profit Qtr Cr 927742714997
    Depreciation Qtr Cr 415389358364
    Interest Qtr Cr 267248233249
    Tax Qtr Cr 55423582
    Net Profit Qtr Cr 660126101313
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 11,550
    Operating Expenses Annual Cr 8,663
    Operating Profit Annual in Cr 2,512
    Depreciation Cr 1,113
    Interest Annual Cr 419
    Tax Annual Cr 254
    Net Profit Annual Cr 463
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 1,853
    Cash from Investing Activity Annual Cr -14,282
    Cash from Financing Annual Activity Cr 13,049
    Net Cash Flow Annual Cr 619
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 17,867
    Fixed Assets Annual Cr 20,649
    Total Non Current Assets Annual Cr 39,709
    Total Current Assets Annual Cr 12,334
    Total Assets Annual Cr 52,043
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 187
    ROE Annual % 3
    ROCE Annual % 4
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 26
    Sign Up to Know More
    Invest in Biocon

    Biocon Technicals

    EMA & SMA

    Current Price
    ₹306.4
    +14.75 (5.06%)
    pointer
    • Bullish Moving Average
    • ___
    • 16
    • Bearish Moving Average
    • ___
    • 0
    • 20 Day
    • ₹275.84
    • 50 Day
    • ₹271.06
    • 100 Day
    • ₹266.69
    • 200 Day
    • ₹262.51
    • 20 Day
    • ₹273.42
    • 50 Day
    • ₹270.88
    • 100 Day
    • ₹267.34
    • 200 Day
    • ₹259.62

    Biocon Resistance and Support

    PIVOT
    ₹303.94
    Resistance
    First Resistance 315.87
    Second Resistance 325.33
    Third Resistance 337.27
    RSI 71.24
    MFI 84.32
    MACD Single Line 2.48
    MACD 6.25
    Support
    First Resistance 294.47
    Second Resistance 282.53
    Third Resistance 273.07

    Biocon Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 47,540,799 2,016,680,694 42.42
    Week 20,337,738 861,913,319 42.38
    1 Month 9,454,225 395,375,692 41.82
    6 Month 6,691,081 278,081,334 41.56

    Biocon Result Highlights

    Biocon Synopsis

    NSE-Medical-Biomed/Biotech

    Biocon is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1992.90 Cr. and Equity Capital is Rs. 600.30 Cr. for the Year ended 31/03/2023. Biocon Ltd. is a Public Limited Listed company incorporated on 29/11/1978 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L24234KA1978PLC003417 and registration number is 003417.
    Market Cap 36,786
    Sales 2,101
    Shares in Float 46.82
    No of funds 253
    Yield 0.49
    Book Value 3.37
    U/D Vol ratio 2.4
    LTDebt / Equity 12
    Alpha -0.06
    Beta 1.5

    Biocon

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 60.64%60.64%60.64%60.64%
    Mutual Funds 8.57%9.31%8.26%7.47%
    Insurance Companies 5.01%5.12%5.76%5.09%
    Foreign Portfolio Investors 5.63%6.55%7.97%9.52%
    Financial Institutions/ Banks 0.01%
    Individual Investors 15.53%14.47%13.61%13.34%
    Others 4.61%3.91%3.76%3.94%

    Biocon Management

    Name Designation
    Ms. Kiran Mazumdar Shaw Executive Chairperson
    Mr. Siddharth Mittal Managing Director & CEO
    Prof. Ravi Rasendra Mazumdar Non Exe.Non Ind.Director
    Mr. Eric Vivek Mazumdar Non Exe.Non Ind.Director
    Mr. Meleveetil Damodaran Lead Independent Director
    Dr. Vijay Kumar Kuchroo Independent Director
    Mr. Bobby Kanubhai Parikh Independent Director
    Mr. Peter John Bains Independent Director
    Mr. Naina Lal Kidwai Independent Director

    Biocon Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Biocon Corporate Action

    Date Purpose Remarks
    2024-05-16 Audited Results & Final Dividend
    2024-02-08 Quarterly Results
    2023-11-10 Quarterly Results
    2023-08-10 Quarterly Results
    2023-05-23 Audited Results & Final Dividend
    Date Purpose Remarks
    2023-07-07 FINAL Rs.1.50 per share(30%)Final Dividend
    2022-07-01 FINAL Rs.0.50 per share(10%)Final Dividend

    Biocon MF Shareholding

    Name Amount(cr)
    Parag Parikh Flexi Cap Regular Growth 60,559
    Kotak Equity Arbitrage Fund Growth 40,051
    Mirae Asset Large Cap Fund Regular Growth 37,885
    ICICI Prudential Multi-Asset Fund Growth 36,843
    SBI Balanced Advantage Fund Regular Growth 28,823

    About Biocon

    Biocon limited is a biopharmaceutical company in India and it is Asia's largest biotechnology company. The company was founded by Kiran Mazumdar-Shaw in 1978 and is headquartered in Bangalore, India. The company has more than 13,500  employees. It focuses on all phases of the product cycle from researching to development and then introducing them to the market.  They mainly concentrate on the research and development of advanced therapies for the treatment of cancer, diabetes, and autoimmune disease. The company's medicines are helping the lives of patients in more than 120 countries by providing access to all their medicines and therapies. 

    Some of Biocon's important brands in India are INSUGEN (rh-insulin), BIOMAb EGFR (Nimotuzumab), CANMAb (Trastuzumab),KRABEVA (Bevacizumab), ALZUMAb(Itolizumab), BLISTO (Glimepiride + Metformin), BASALOG (Glargine), etc. 

    Biocon FAQs

    What is Share Price of Biocon ?

    Biocon share price is ₹306 As on 28 April, 2024 | 02:54

    What is the Market Cap of Biocon ?

    The Market Cap of Biocon is ₹36786.4 Cr As on 28 April, 2024 | 02:54

    What is the P/E ratio of Biocon ?

    The P/E ratio of Biocon is 30.7 As on 28 April, 2024 | 02:54

    What is the PB ratio of Biocon ?

    The PB ratio of Biocon is 1.6 As on 28 April, 2024 | 02:54

    Is it a good time to invest in Biocon Limited?

    Biocon has an operating revenue of Rs.7,290.70 Cr. on a trailing 12-month basis. An annual revenue growth of 14% is good, Pre-tax margin of 16% is great. However, analysts are of mixed views on the stock.

    How many times has Biocon Limited given dividends since 2004?

    Biocon Ltd. has declared 17 dividends since July 1, 2004.

    What is the stock price CAGR of Biocon Limited?

    The stock price CAGR of Biocon Limited for 10 Years is 24%, 5 Years is 17%, 3 Years is 5%, 1 Year is -21%.

    What is the debt-to-equity ratio of Biocon Limited?

    The debt-to-equity ratio of Biocon Limited is 39% which signals a healthy balance sheet.

    What is the ROE of the Biocon Limited?

    The ROE of Biocon Limited is 9% which is fair but needs improvement.

    Who is the Managing Director of Biocon Limited?

    Mr. Siddharth Mittal is the Managing Director and CEO of Biocon Limited.

    Is Biocon a good stock to buy?

    According to the record analysis of moneyworks4me, Biocom limited is an average quality company. 

    How to buy shares of Biocon Ltd?

    The company's shares can be bought online or offline by opening a Demat account with 5Paisa and verifying the KYC documents.

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.